Synthesis and enhancing effect of transkarbam 12 on the transdermal delivery of theophylline, clotrimazole, flobufen, and griseofulvin

. 2006 May ; 23 (5) : 912-9. [epub] 20060502

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid16715381

PURPOSE: Dodecyl-6-aminohexanoate (DDEAC) is a transdermal permeation enhancer with excellent activity, low toxicity, and no dermal irritation. We hypothesized that DDEAC reacts with air CO2 to form a two-chain ammonium carbamate--Transkarbam 12 (T12)--which is responsible for the enhancing effect. METHODS: DDEAC and T12 were synthesized, their structures were confirmed by spectral methods, and their enhancing activity was studied using the Franz diffusion cell and human skin. A high-performance liquid chromatography method was developed for determination of T12, and its biodegradability was evaluated using porcine esterase. RESULTS: Only the carbamate salt T12 was responsible for the high enhancing activity; DDEAC tested under argon to avoid reaction with CO2 was inactive. T12 enhanced transdermal permeation of drugs covering a wide range of physicochemical properties, including theophylline (enhancement ratio up to 55.6), clotrimazole (7.7), flobufen (5.0), and griseofulvin (24). The activity was pH-dependent, further confirming the importance of the carbamate structure. The metabolization of T12 followed a second-order kinetics with t(1/2) = 31 min. CONCLUSION: Our results indicate that T12 is a promising biodegradable permeation enhancer for a wide range of drugs, and the structurally novel group of carbamate enhancers warrants further investigation.

Zobrazit více v PubMed

Curr Med Chem. 2005;12(19):2273-91 PubMed

J Pharm Sci. 1996 Feb;85(2):150-4 PubMed

Arzneimittelforschung. 1997 May;47(5):648-52 PubMed

J Invest Dermatol. 1975 Mar;64(3):190-5 PubMed

Chem Phys Lipids. 2004 Apr;129(1):97-109 PubMed

Arch Dermatol. 1982 Jul;118(7):474-7 PubMed

Chem Rev. 2003 Oct;103(10):3857-98 PubMed

J Biophys Biochem Cytol. 1955 Jan;1(1):13-6 PubMed

J Control Release. 2005 May 5;104(1):41-9 PubMed

Drug Des Deliv. 1990 Jun;6(2):87-100 PubMed

Pharm Res. 1993 Jul;10(7):1015-9 PubMed

Nat Rev Drug Discov. 2004 Feb;3(2):115-24 PubMed

Adv Drug Deliv Rev. 2004 Mar 27;56(5):603-18 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...